SPAN Span-America Medical Systems, Inc.

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

 

 

Date of Report (Date of earliest event reported)

February 2, 2016

 

 

SPAN-AMERICA MEDICAL SYSTEMS, INC.

(Exact name of registrant as specified in its charter)

 

     

South Carolina	0-11392	57-0525804
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

 

 

70 Commerce Center, Greenville, South Carolina	29615
(Address of principal executive offices)	(Zip Code)

 

Registrant’s telephone number, including area code

(864) 288-8877

 

N/A

(Former name or former address, if changed since last report.)

     

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

[ ]	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

[ ]	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

[ ]	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

[ ]	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

Item 1.01.

Entry into a Material Definitive Agreement.

 

On February 2, 2016, Span-America Medical Systems, Inc. (the “Company”) and Nipro Consumer Healthcare, Inc., d/b/a P.J. Noyes Company (“PJ Noyes”), entered into an Amendment No. 1 to License and Distribution Agreement effective February 1, 2016 amending the License and Distribution Agreement effective October 4, 2010 by and between the Company and PJ Noyes to extend the term of the agreement through December 31, 2020. 

 

A copy of the Amendment No. 1 to License and Distribution Agreement is filed herewith as Exhibit 10.1 hereto, and the description of the amendment set forth above is qualified in its entirety by reference to the text thereof which is incorporated herein by reference.

 

 

Item 9.01.

Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit Number	Description of Exhibit
10.1	Amendment No. 1 to License and Distribution Agreement effective February 1, 2016 by and between Nipro Consumer Healthcare, Inc., d/b/a P.J. Noyes Company and Span-America Medical Systems, Inc.

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

		SPAN-AMERICA MEDICAL SYSTEMS, INC.
		(Registrant)
Date: February 8, 2016
	By:	/s/ Richard C. Coggins
		Richard C. Coggins
		Chief Financial Officer

 

 

EXHIBIT INDEX

 

Exhibit	Description
10.1	Amendment No. 1 to License and Distribution Agreement effective February 1, 2016 by and between Nipro Consumer Healthcare, Inc., d/b/a P.J. Noyes Company and Span-America Medical Systems, Inc.

 

Exhibit 10.1

 

 

AMENDMENT NO. 1

TO LICENSE AND DISTIBUTION AGREEMENT

 

 

 

THIS AMENDMENT NO. 1 (“Amendment”), effective this 1^st day of February, 2016 (the “Amendment Effective Date”), is entered into by and between NIPRO CONSUMER HEALTHCARE, INC., d/b/a P.J. NOYES COMPANY, a New Hampshire corporation, with its principal offices located at 89 Bridge Street, Lancaster, New Hampshire 03584 (“LICENSOR”), and Span-America Medical Systems, Inc., a South Carolina corporation, with its principal offices located at 70 Commerce Center, Greenville, South Carolina 29615 (“LICENSEE”) Licensor and Licensee are hereinafter individually referred to as “Party” and collectively as the “Parties.

 

 

Background

 

WHEREAS, Licensor and Licensee entered into a License and Distribution Agreement effective October 4, 2010 (the “Agreement”); and

 

WHEREAS, the parties desire to amend the Agreement as provided herein.

 

NOW, THEREFORE, in consideration of the premises and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Licensor and Licensee agree as follows:

 

Amendment

 

1.

The term of the Agreement is extended through December 31, 2020.

 

Except as expressly modified by this Amendment, the terms and provisions of the Agreement are hereby ratified and confirmed.

 

The Parties have caused this Amendment to be executed by their respective duly authorized officers.

 

SPAN-AMERICA MEDICAL SYSTEMS, INC.			NIPRO CONSUMER HEALTHCARE, INC., d/b/a P.J.
			NOYES COMPANY
By:	/s/ Richard C. Coggins		By:	/s/ Dean G. Sorrentino
Name:	Richard C. Coggins		Name:	Dean G. Sorrentino
Title:	CFO		Title:	CFO
Date:	2/1/16		Date:	2/2/16